Morris, Valerie (2014) A New Drug Bites AML. Science Spotlight, 4 (1).
Preview |
Text
A New Drug Bites AML.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (280kB) | Preview |
Article URL: http://www.bloodjournal.org/content/123/4/554
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | Laszlo GS, Gudgeon CJ, Harrington KH, Dell'aringa J, Newhall KJ, Means GD, Sinclair AM, Kischel R, Frankel SR, Walter RB. 2013. Blood. Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML. Blood. Epub ahead of print, doi: 10.1182/blood-2013-09-527044. See also: Topp MS, Gökbuget N, Zugmaier G, Degenhard E, Goebeler ME, Klinger M, Neumann SA, Horst HA, Raff T, Viardot A, Stelljes M, Schaich M, Köhne-Volland R,Brüggemann M, Ottmann OG, Burmeister T, Baeuerle PA, Nagorsen D, Schmidt M, Einsele H, Riethmüller G, Kneba M, Hoelzer D, Kufer P, Bargou RC. 2012. Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL. Blood 120:5185-5187. |
| Collections: | Science Spotlight |
| Depositing User: | Users 60 not found. |
| Date Deposited: | 19 Mar 2015 19:23 |
| Last Modified: | 19 Mar 2015 19:23 |
| URI: | http://authors.fhcrc.org/id/eprint/699 |
Repository Administrators Only
 |
View Item |
